Yu, T.-C., & Chou, W.-C. (2026). Challenges of Hepatitis B Virus Reactivation and CD19 Testing Following Tafasitamab Plus Lenalidomide for Relapsed Diffuse Large B-Cell Lymphoma. Journal of Medical Cases, 17(5), 231-237. https://doi.org/10.14740/jmc5313